Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Intro covering typical applications and conditions where Pow or Pos is preferable, with implications for project planning.
19,818 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Rivian stock rallied today as investors weighed new partnerships, production progress, and autonomous-driving milesto...
JPMorgan has begun a pilot that compares junior bankers' self-reported hours to computer activity, including keystrok...
Bitcoin briefly topped $80,000 again as traders weigh whether the move signals real demand or a looming reversal. Ana...
Apple’s measured AI approach contrasts with Microsoft’s aggressive spending, signaling a shift in investor bets as th...
Peabody Energy shares fell nearly 6% after a quarterly report that missed profitability targets. This article breaks ...
A straightforward, low-cost Vanguard strategy could outpace the S&P 500 in 2026. This guide explains why and shows co...
The 2026 HousingWire Homebuilder Rankings broaden the field, adding new metrics that measure profitability and local ...
DZ Bank moves Fortinet to Hold with a $125 price target, signaling a cautious turn in cybersecurity equities as growt...
Private AI secondaries are heating up as Anthropic eyes a potential IPO. Market chatter warns the scene is a pressure...
A shrinking market breadth exposes investors to a narrow rally as earnings revisions pile up around AI-related names....
New data shows wealth grows more from steady saving and patient investing than from big salaries. The piece outlines ...